A Prospective Registry for the Use of CypherTM Sirolimus-Eluting Stents In Patients With Coronary Artery Disease Treated With Percutaneous Coronary Interventions at Scripps Clinic
Phase of Trial: Phase IV
Latest Information Update: 21 Dec 2012
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 21 Dec 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 21 Dec 2012 Actual end date Apr 2012 added as reported by ClinicalTrials.gov.
- 09 Oct 2009 Actual number of patients (859) added as reported by ClinicalTrials.gov.